生物信息学用于抗菌肽预测和分子设计的研究进展

摘要/Abstract

摘要： 抗菌肽（AMP）以其特异性抗菌、抗病毒、抗肿瘤功能及快速、广谱、高效等特点，迅速成为具有重要研究价值的新型生物活性肽。寻找合适方法最大限度提高其活性，降低毒性和成本，是新型抗菌肽药物研发过程中面临的首要问题。应用生物信息学工具对新型抗菌肽进行预测或对天然抗菌肽进行分子设计成为解决这一问题的关键。对生物信息学在抗菌肽预测和优化设计中的最新进展进行综述，以期扩大抗菌肽的来源，提高现有抗菌肽的生物活性。

关键词: 抗菌肽, 生物信息学, 活性肽预测, 分子设计

Abstract: Antimicrobial peptides（AMPs）are being increasingly recognized as novel bioactive peptide with critical research value owing to their activities of anti-bacterium，antivirus and antitumor as well as properties of rapidness，broad-spectrum，and high efficiency. Whereas a crucial issue in AMP drug development is how to seek appropriate approaches for maximally improving the bioactivity and decreasing the toxicity and production cost. Applying bioinformatics tools to predict novel AMP and to carry out the molecular design of natural AMP is the key to solve this problem. The new progress on bioinformatics involved in AMP prediction and optimal design is reviewed. in order to expand the sources of new AMPs and elevate the bioactivities of known AMPs.

Key words: antimicrobial peptides（AMP）, bioinformatics, active peptide prediction, molecular design

中图分类号:

10.13560/j.cnki.biotech.bull.1985.2016.12.005

肖轶尘,熊浩,谢川,吕农华. 生物信息学用于抗菌肽预测和分子设计的研究进展[J]. 生物技术通报, 2016, 32(12): 23-28.

XIAO Yi-chen,XIONG Hao,XIE Chuan,Lü Nong-hua. Research Progress on the Application of Bioinformatics in Prediction and Molecular Design of Antimicrobial Peptide[J]. Biotechnology Bulletin, 2016, 32(12): 23-28.

参考文献

[1] Zasloff M. Antimicrobial peptides of multicellular organisms[J] . Nature, 2002, 415：389-395.
[2] Cole JN, Nizet V. Bacterial evasion of host antimicrobial peptide defenses[J] . Microbiol Spectrum, 2016, 4. doi：10. 1128/microbiolspec. VMBF-0006-2015.
[3] Tam JP, Wang S, Wong KH, et al. Antimicrobial peptides from plants[J] . Pharmaceuticals, 2015, 8：711-757.
[4] Segev-Zarko L, Saar-Dover R, Brumfeld V, et al. Mechanisms of biofilm inhibition and degradation by antimicrobial peptides[J] . Biochem J, 2015, 468：259-270.
[5] de Melo ET, Estrela AB, Santos ECG, et al. Structural characterization of a novel peptide with antimicrobial activity from the venom gland of the scorpion Tityus stigmurus：Stigmurin[J] . Peptides, 2015, 68：3-10.
[6] Ramírez-Carreto S, Jiménez-Vargas JM, Rivas-Santiago B, et al. Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity[J] . Peptides, 2015, 73：51-59.
[7] Bard GCV, Nascimento VV, Ribeiro SFF, et al. Characterization of peptides from Capsicum annuum hybrid seeds with inhibitory activity against α-Amylase, serine proteinases and fungi[J] . Protein J, 2015, 34：122-129.
[8] Hellinger R, Koehbach J, Puigpinós A, et al. Inhibition of human prolyl oligopeptidase activity by the cyclotide psysol 2 isolated from psychotria solitudinum[J] . J Nat Prod, 2015, 78：1073-1082.
[9] Kang SJ, Park SJ, Mishig-Ochir T, et al. Antimicrobial peptides：therapeutic potentials[J] . Expert Rev Anti Infe, 2014, 12：1477-1486.
[10] Fjell CD, Hiss JA, Hancock REW, et al. Designing antimicrobial peptides：form follows function[J] . Nat Rev Drug Discov, 2012, 11：37-51.
[11] Pearson CS, Kloos Z, Murray B, et al. Combined bioinformatic and rational design approach to develop antimicrobial peptides against Mycobacterium tuberculosis[J] . Antimicrob Agents Chemother, 2016. 60（5）：2757-2764.
[12] Wang G, Li X, Wang Z. APD3：the antimicrobial peptide database as a tool for research and education[J] . Nucleic Acids Res, 2016, 44（D1）：D1087-1093.
[13] Fjell CD, Hancock REW, Cherkasov A. AMPer：a database and an automated discovery tool for antimicrobial peptides[J] . Bioinformatics, 2007, 23：1148-1155.
[14] Waghu FH, Barai RS, Gurung P, et al. CAMPR3：a database on sequences, structures and signatures of antimicrobial peptides[J] . Nucleic Acids Res. 2015：gkv1051.
[15] Louis-Jeune C, Andrade-Navarro MA, Perez-Iratxeta C. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra[J] . Proteins, 2012, 80：374-381.
[16] Regberg J, Vasconcelos L, Madani F, et al. pH-responsive PepFect cell-penetrating peptides[J] . Int J Pharm, 2016, 501：32-38.
[17] Kelley LA, Mezulis S, Yates CM, et al. The Phyre2 web portal for protein modeling, prediction and analysis[J] . Nat Protoc, 2015, 10：845-858.
[18] Rei?er S, Strandberg E, Steinbrecher T, et al. 3D hydrophobic moment vectors as a tool to characterize the surface polarity of amphiphilic peptides[J] . Biophys J, 2014, 106：2385-2394.
[19] Rice P, Longden I, Bleasby A. EMBOSS：the European molecular biology open software suite[J] . Trends Genet, 2000, 16：276-277.
[20] Gautier R, Douguet D, Antonny B, et al. HELIQUEST：a web server to screen sequences with specific α-helical properties[J] . Bioinformatics, 2008, 24：2101-2102.
[21] Lear S, Cobb SL. Pep-Calc. com：a set of web utilities for the calculation of peptide and peptoid properties and automatic mass spectral peak assignment[J] . J Comput Aid Mol Des, 2016, 30：271-277.
[22] Wang Z, Wang G. APD：the antimicrobial peptide database[J] . Nucleic Acids Res, 2004, 32：D590-D592.
[23] Lata S, Sharma BK, Raghava GPS. Analysis and prediction of antibacterial peptides[J] . BMC Bioinformatics, 2007, 8：263. doi：10. 1186/1471-2105-8-263.
[24] Lata S, Mishra NK, Raghava GPS. AntiBP2：improved version of antibacterial peptide prediction[J] . BMC Bioinformatics, 2010, 11：S19. doi：10. 1186/1471-2105-11-S1-S19.
[25] Nagarajan V, Kaushik N, Murali B, et al. A Fourier Transformation based method to mine peptide space for antimicrobial activity[J] . BMC Bioinformatics, 2006, 7：S2. doi：10. 1186/1471-2105-7-S2-S2.
[26] Cherkasov A, Hilpert K, Jenssen H, et al. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs[J] . ACS Chem Biol, 2008, 4：65-74.
[27] Juretic D, Vukicevic D, Ilic N, et al. Computational design of highly selective antimicrobial peptides[J] . J Chem Inf Model, 2009, 49：2873-2882.
[28] Yount NY, Yeaman MR. Multidimensional signatures in antimicrobial peptides[J] . Proc Natl Acad Sci USA, 2004, 101（19）：7363-7368.
[29] Schutte BC, Mitros JP, Bartlett JA, et al. Discovery of five conserved β-defensin gene clusters using a computational search strategy[J] . Proc Natl Acad Sci USA, 2002, 99：2129-2133.
[30] Wachinger M, Kleinschmidt A, Winder D, et al. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression[J] . J Gen Virol, 1998, 79：731-740.
[31] Lehrer RI. Multispecific myeloid defensins[J] . Curr Opin Hematol, 2007, 14：16-21.
[32] Ireland DC, Wang CKL, Wilson JA, et al. Cyclotides as natural anti-HIV agents[J] . Pept Sci, 2008, 90：51-60.
[33] Férir G, Petrova MI, Andrei G, et al. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications[J] . PLoS One, 2013, 8：e64010.
[34] Wang G, Watson KM, Peterkofsky A, et al. Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database[J] . Antimicrob Agents Ch, 2010, 54：1343-1346.
[35] Wang G, Watson KM, Buckheit RW. Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins[J] . Antimicrob Agents Chemother, 2008, 52：3438-3440.
[36] Li X, Li Y, Han H, et al. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region[J] . J Am Chem Soc, 2006, 128：5776-5785.
[37] Torrent M, Nogués VM, Boix E. A theoretical approach to spot active regions in antimicrobial proteins[J] . BMC Bioinformatics, 2009, 10：373. doi：10. 1186/1471-2105-10-373.
[38] Merrifield RB, Juvvadi P, Andreu D, et al. Retro and retroenantio analogs of cecropin-melittin hybrids[J] . P Natl Acad Sci USA, 1995, 92：3449-3453.
[39] Li X, Li Y, Peterkofsky A, et al. NMR studies of aurein 1. 2 analogs[J] . BBA-Biomembranes, 2006, 1758：1203-1214.
[40] Villain M, Jackson PL, Manion MK, et al. De novo design of peptides targeted to the EF hands of calmodulin[J] . J Biol Chem, 2000, 275：2676-2685.
[41] Blondelle SE, Houghten RA. Design of model amphipathic peptides having potent antimicrobial activities[J] . Biochemistry, 1992, 31：12688-12694.
[42] Kang SJ, Won HS, Choi WS, et al. De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface[J] . J Pept Sci, 2009, 15：583-588.
[43] Wang G, Li X, Wang Z. APD2：the updated antimicrobial peptide database and its application in peptide design[J] . Nucleic Acids Res, 2009, 37：D933-D937.
[44] Monroc S, Badosa E, Feliu L, et al. De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria[J] . Peptides, 2006, 27：2567-2574.
[45] Duval E, Zatylny C, Laurencin M, et al. KKKKPLFGLFFGLF：a cationic peptide designed to exert antibacterial activity[J] . Peptides, 2009, 30：1608-1612.